Thermo Fisher Scientific Reports Second Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- Oil rises 1% on US-Iran deal doubts; IEA warns of supply glut
Thermo Fisher Scientific (TMO) PT Raised to $260 at Deutsche Bank
July 25, 2018 1:57 PM EDTDeutsche Bank raised its price target on Thermo Fisher Scientific (NYSE: TMO) to $260.00 (from $245.00) while maintaining a Buy rating following results.
Analyst Dan Leonard said TMO's upwardly revised organic sales growth guidance of 6% appears conservative. End markets were robust, led by China and biopharma.
... MoreThermo Fisher Scientific (TMO) Tops Q2 EPS by 13c, Revenues Beat; Boosts FY18 EPS/Revenue Outlook
July 25, 2018 6:03 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $2.75, $0.13 better than the analyst estimate of $2.62. Revenue for the quarter came in at $6.08 billion versus the consensus estimate of $5.89 billion.
Second Quarter 2018 Highlights
Grew revenue 22% to $6.08 billion.Increased GAAP diluted earnings per share (EPS) 19% to $1.85.Increased adjusted EPS 20% to $2.75.Launched suite of new mass spectrometry systems for life sciences and applied markets highlighted by the Thermo Scientific Q Exactive UHMR for protein research as well as new products for clinical research and diagnostics, including the Ion Torrent... More
